Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 2;13(3):543.
doi: 10.3390/diagnostics13030543.

Overlap of Suspicious and Non-Suspicious Features in the Ultrasound Evaluations of Leiomyosarcoma: A Single-Center Experience

Affiliations

Overlap of Suspicious and Non-Suspicious Features in the Ultrasound Evaluations of Leiomyosarcoma: A Single-Center Experience

Francesca Arezzo et al. Diagnostics (Basel). .

Abstract

Leiomyosarcoma (LMS) is a rare type of mesenchymal tumor. Suspecting LMS before surgery is crucial for proper patient management. Ultrasound is the primary method for assessing myometrial lesions. The overlapping of clinical, laboratory, as well as ultrasound features between fibroids and LMS makes differential diagnosis difficult. We report our single-center experience in ultrasound imaging assessment of LMS patients, highlighting that misleading findings such as shadowing and absent or minimal vascularization may also occur in LMS. To avoid mistakes, a comprehensive evaluation of potentially overlapping ultrasound features is necessary in preoperative ultrasound evaluations of all myometrial tumors.

Keywords: gynecological ultrasound; leiomyosarcoma; myometrial tumors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Ultrasound images of LMS patients of our series. Panel (A). single myometrial tumor with in-homogeneous echogenicity of the solid tissue, irregular tumor borders, and moderate intralesional vascularization, without cystic areas and with fan-shaped shadowing. The lesion had a soft consistency at probe pressure. Panel (B). myometrial tumor with inhomogeneous echogenicity of the solid tissue, irregular tumor borders, and irregular cystic areas with anechoic content, with fan-shaped shadowing. The vascularization was minimal and intralesional. The lesion had a soft consistency under probe pressure. Panel (C). single myometrial tumor with in-homogeneous echogenicity of the solid tissue, irregular tumor borders, and irregular cystic areas with low-level content and shadows. The vascularization was minimal and intralesional. The lesion had a soft consistency under probe pressure. Panel (D). single myometrial tumor with in-homogeneous echogenicity of the solid tissue, irregular tumor borders, irregular cystic areas with anechoic content, and shadows. The vascularization was moderate and intralesional. The lesion had a soft consistency under probe pressure. Panel (E). single myometrial tumor with inhomogeneous echogenicity of the solid tissue, irregular tumor borders, irregular cystic areas with anechoic content, and absence of shadows. The vascularization was minimal and intralesional. The lesion had a soft consistency under probe pressure. Panel (F). myometrial tumor with in-homogeneous echogenicity of the solid tissue, irregular tumor borders, irregular cystic areas with low-level content, and absence of shadows. The vascularization was moderate and intralesional. The lesion had a soft consistency under probe pressure. Panel (G). single myometrial tumor with inhomogeneous echogenicity of the solid tissue, irregular cystic areas with anechoic content, without shadows, and with minimal intralesional vascularization. The lesion had regular tumor borders and a soft consistency under probe pressure.

References

    1. Raine-Bennett T., Tucker L.-Y., Zaritsky E., Littell R.D., Palen T., Neugebauer R., Axtell A., Schultze P.M., Kronbach D.W., Embry-Schubert J., et al. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated with Morcellation. Obstet. Gynecol. 2016;127:29–39. doi: 10.1097/AOG.0000000000001187. - DOI - PubMed
    1. Tropé C.G., Abeler V.M., Kristensen G.B. Diagnosis and Treatment of Sarcoma of the Uterus. A Review. Acta Oncol. Stockh. Swed. 2012;51:694–705. doi: 10.3109/0284186X.2012.689111. - DOI - PubMed
    1. Lim D., Alvarez T., Nucci M.R., Gilks B., Longacre T., Soslow R.A., Oliva E. Interobserver Variability in the Interpretation of Tumor Cell Necrosis in Uterine Leiomyosarcoma. Am. J. Surg. Pathol. 2013;37:650–658. doi: 10.1097/PAS.0b013e3182851162. - DOI - PubMed
    1. Liu J., Wang Z. Advances in the Preoperative Identification of Uterine Sarcoma. Cancers. 2022;14:3517. doi: 10.3390/cancers14143517. - DOI - PMC - PubMed
    1. Żak K., Zaremba B., Rajtak A., Kotarski J., Amant F., Bobiński M. Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions. Cancers. 2022;14:1966. doi: 10.3390/cancers14081966. - DOI - PMC - PubMed

LinkOut - more resources